<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03076710</url>
  </required_header>
  <id_info>
    <org_study_id>20140496</org_study_id>
    <nct_id>NCT03076710</nct_id>
  </id_info>
  <brief_title>Post-Operative Pain Management Following Spine Surgery</brief_title>
  <acronym>EXPAREL</acronym>
  <official_title>Two-Stage, Pilot, Prospective, Observational Study of Post-Operative Pain Management Following Spine Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Miami</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Pacira Pharmaceuticals, Inc</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Miami</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of this pilot study is to assess the feasibility of comparing two
      standardized approaches to manage post-operative pain following spine surgery: one approach
      using Patient Controlled Analgesia (PCA) devices to deliver opioid analgesics, and the other
      approach using EXPAREL® infiltration at the site of surgery and nurse-administered opioid
      analgesics.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study will assess the feasibility of the methods proposed, including recruitment,
      eligibility, standardization of both post-operative pain management approaches, and
      assessment of clinical, hospital efficiency, medication use, health services use, and
      economic outcomes.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 31, 2017</start_date>
  <completion_date type="Anticipated">March 2022</completion_date>
  <primary_completion_date type="Anticipated">March 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Pain severity at the site of surgery</measure>
    <time_frame>4 hours post surgery</time_frame>
    <description>Numerical Rating Scale 0 (no pain) to 10 (worst pain imaginable).</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Pain Management</condition>
  <condition>Analgesia</condition>
  <condition>Anesthetic</condition>
  <arm_group>
    <arm_group_label>Opioids delivered through PCA</arm_group_label>
    <description>PCA devices used to deliver opioids</description>
  </arm_group>
  <arm_group>
    <arm_group_label>EXPAREL® infiltration</arm_group_label>
    <description>EXPAREL® infiltration at the site of surgery and nurse-administered opioid as needed</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Opioids delivered through PCA</intervention_name>
    <description>IV up to 1 mg. morphine every 10 minutes on request and oral opioids up to 2 tablets of Percocet every 4 hours</description>
    <arm_group_label>Opioids delivered through PCA</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>EXPAREL® infiltration</intervention_name>
    <description>22 gauge / 3.5&quot; needle, into dermal/fascial/muscular/subcutaneous layers and up to 4mg IV morphine every 60 minutes on request and standardized oral opioids on request</description>
    <arm_group_label>EXPAREL® infiltration</arm_group_label>
    <other_name>Bupivacaine</other_name>
    <other_name>Marcaine</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients undergoing primary, single level, lumbar fusion surgical procedures.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18-65

          -  Ability to speak, read, and write in English or Spanish

          -  Primary indication is low back pain, radiculopathy, disc degeneration, disc
             herniation, foraminal stenosis, or mild 1-level spondylolisthesis or deformity

          -  Scheduled to undergo primary, single level, lumbar fusion surgical procedure at the
             study center in the next 30 days

          -  Willing to provide informed consent, participate in study, and comply with study
             protocol

        Exclusion Criteria:

          -  Body mass index &gt;35

          -  Pregnant or contemplating pregnancy prior to surgery

          -  Current or previous psychiatric, behavioral, or emotional disorder that may interfere
             with postsurgical pain, analgesia, or opioid use according to treating surgeon

          -  Prior treatment for alcohol, recreational drug, or opioid abuse

          -  Chronic inflammatory conditions (e.g. Crohn's, lupus, rheumatoid arthritis)

          -  Chronic neurologic conditions (e.g. multiple sclerosis, Parkinson's)

          -  Serious spinal conditions (e.g. cauda equina syndrome, infection, tumor, fracture)

          -  Hypersensitivity or allergy to local anesthetics

          -  Previous surgery in lumbar spine (i.e. other than microdiscectomy);

          -  Continuous (e.g. daily) opioid consumption for more than 30 days prior to surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Steven Vanni, DO, DC</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Miami</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Karthik Madhavan, MBBS</last_name>
    <phone>3052436946</phone>
    <email>karthik.madhavan@jhsmiami.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Miami Hospital</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33136</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karthik Madhavan, MBBS</last_name>
      <email>karthik.madhavan@jhsmiami.org</email>
    </contact>
    <investigator>
      <last_name>Steven Vanni, DO, DC</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 24, 2017</study_first_submitted>
  <study_first_submitted_qc>March 6, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 10, 2017</study_first_posted>
  <last_update_submitted>February 1, 2018</last_update_submitted>
  <last_update_submitted_qc>February 1, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 5, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Miami</investigator_affiliation>
    <investigator_full_name>Steven Vanni</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>spine surgery</keyword>
  <keyword>post-operative pain</keyword>
  <keyword>patient controlled analgesia</keyword>
  <keyword>Exparel®</keyword>
  <keyword>bupivacaine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>Analgesics, Opioid</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

